Constitutively active FGFR3 with Lys650Glu mutation enhances bortezomib sensitivity in plasma cell malignancy. (Q39601586)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Constitutively active FGFR3 with Lys650Glu mutation enhances bortezomib sensitivity in plasma cell malignancy. |
scientific article published on January 2011 |
Statements
Constitutively active FGFR3 with Lys650Glu mutation enhances bortezomib sensitivity in plasma cell malignancy (English)
Masayasu Otsuka
Masao Mizuki
Jiro Fujita
Sumin Kang
Yuzuru Kanakura
1 January 2011